2002
DOI: 10.1016/s0167-7799(02)02075-9
|View full text |Cite
|
Sign up to set email alerts
|

Lactobacilli as live vaccine delivery vectors: progress and prospects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
155
0
6

Year Published

2003
2003
2014
2014

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 212 publications
(162 citation statements)
references
References 62 publications
1
155
0
6
Order By: Relevance
“…Gilliland, 1990;Goldin, 1998;Vaughan et al, 1999;Gorbach, 2000;Rolfe, 2000;Mercenier et al, 2003). Also, in recent years, selected Lactobacillus species have been used as vaccine delivery systems, which can be administered orally and can effectively induce protective immune responses (Mercenier et al, 1996;Wells et al, 1996;Pouwels et al, 2001;Seegers, 2002;Scheppler et al, 2002).…”
Section: Introductionmentioning
confidence: 99%
“…Gilliland, 1990;Goldin, 1998;Vaughan et al, 1999;Gorbach, 2000;Rolfe, 2000;Mercenier et al, 2003). Also, in recent years, selected Lactobacillus species have been used as vaccine delivery systems, which can be administered orally and can effectively induce protective immune responses (Mercenier et al, 1996;Wells et al, 1996;Pouwels et al, 2001;Seegers, 2002;Scheppler et al, 2002).…”
Section: Introductionmentioning
confidence: 99%
“…As lactobacilli are commensals of the gut and are generally regarded as safe (GRAS-status), lactobacilli are good candidates for use as production and delivery hosts of heterologous proteins in food but also health care products. Genetically engineered lactobacilli expressing bacterial or viral proteins on the cell surface can potentially be used as oral vaccines [1,2]. On the other hand, Lactobacillus recombinants secreting tolerogenic autoantigens can be used to induce systemic peripheral T-cell tolerance by oral administration for treatment of autoimmune disease [1].…”
Section: Introductionmentioning
confidence: 99%
“…In this sense, some scientists are considering the possibility of combining these benefits using genetic engineering (Steidler, 2003;Abbot, 2004). There are evidences that some genetically-modified bacteria may be efficient vehicles for drugs, vitamins, or vaccines, such as genetically-modified Lactococcus lactis that may secrete medicines to fight intestinal disorders (Seegers, 2002;Steidler et al, 2000;Steidler, 2003;Charng et al, 2006).…”
Section: Substrates and Bacterial Metabolitesmentioning
confidence: 99%